ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 783

$936K Total Retail Price of All Prescriptions

Rank: 58 out of 783

460 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,480 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 641 330 S3 1 2
OMEPRAZOLE 577 304 2 6
LEVOTHYROXINE SODIUM 484 317 3 1
AMLODIPINE BESYLATE 483 365 4 5
LOVASTATIN 431 235 5 58
LISINOPRIL 422 293 6 4
METFORMIN HCL 394 186 7 8
SIMVASTATIN 293 192 8 3
GABAPENTIN 279 142 9 15
TRAMADOL HCL 255 168 10 20
CITALOPRAM HBR 251 202 11 19
WARFARIN SODIUM 230 185 12 10
DONEPEZIL HCL 226 208 13 24
FUROSEMIDE 220 152 14 7
METOPROLOL SUCCINATE 209 133 15 13
CLOPIDOGREL 172 132 16 29
HYDROCHLOROTHIAZIDE 165 87 17 12
TRAZODONE HCL 162 99 18 39
METOPROLOL TARTRATE 162 112 18 9
ATORVASTATIN CALCIUM 159 109 20 11
ATENOLOL 144 99 21 17
GLIMEPIRIDE 133 67 22 34
LANTUS 126 53 23 38
QUETIAPINE FUMARATE 124 37 24 79
SERTRALINE HCL 122 78 25 22
AZITHROMYCIN 121 82 26 41
NAMENDA 119 106 27 32
CYCLOBENZAPRINE HCL 118 43 R 28 63
PREDNISONE 115 90 29 36
RISPERIDONE 113 50 30 67
CYMBALTA 112 64 31 35
NEXIUM 107 59 32 28
NAPROXEN 104 44 33 104
ADVAIR DISKUS 101 56 34 50
PROAIR HFA 98 31 35 56
POTASSIUM CHLORIDE 97 71 36 16
FENTANYL 94 61 S2 37 65
SPIRIVA 94 62 37 59
CRESTOR 93 60 39 27
PANTOPRAZOLE SODIUM 93 51 39 30
FLUOXETINE HCL 92 46 41 45
MELOXICAM 88 68 42 37
ALLOPURINOL 86 53 43 31
PLAVIX 80 59 44 51
ALENDRONATE SODIUM 80 49 44 25
SINGULAIR 80 56 44 90
ROPINIROLE HCL 78 31 47 74
ISOSORBIDE MONONITRATE ER 76 48 48 40
POLYETHYLENE GLYCOL 3350 75 33 49 43
ESCITALOPRAM OXALATE 72 22 50 54
CLONIDINE HCL 71 23 51 60
PRAVASTATIN SODIUM 71 68 51 14
HUMALOG 71 35 51 101
HALOPERIDOL 71 0 51 216
ZETIA 70 36 55 80
JANUVIA 68 41 56 73
MIRTAZAPINE 68 55 56 52
DIOVAN 68 36 56 49
IPRATROPIUM-ALBUTEROL 68 56 56 110
DIVALPROEX SODIUM 66 22 60 72
TAMSULOSIN HCL 66 51 60 26
BENAZEPRIL HCL 66 49 60 85
NYSTOP 65 62 63 231
VENLAFAXINE HCL ER 65 0 63 100
LEVOFLOXACIN 64 48 65 75
OXYBUTYNIN CHLORIDE 63 37 66 96
PAROXETINE HCL 63 24 66 69
ALBUTEROL SULFATE 63 46 66 136
FAMOTIDINE 63 30 66 55
MONTELUKAST SODIUM 63 45 66 160
NOVOLOG 62 34 71 81
CARVEDILOL 61 52 72 21
BUSPIRONE HCL 61 33 72 124
TORSEMIDE 61 45 72 126
KLOR-CON M20 61 48 72 48
NYSTATIN 60 34 76 106
MORPHINE SULFATE ER 59 0 S2 77 107
LANTUS SOLOSTAR 58 46 78 91
INSULIN SYRINGE 58 30 78 82
CEPHALEXIN 57 48 80 70
CIPROFLOXACIN HCL 56 41 81 62
AMITRIPTYLINE HCL 55 22 R 82 77
COMBIVENT 55 39 82 120
HYDRALAZINE HCL 55 36 82 78
TRICOR 54 17 85 134
PEN NEEDLE 53 36 86 103
OXCARBAZEPINE 52 16 87 252
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 31 87 33
PROMETHAZINE HCL 50 30 R 89 97
LEVEMIR FLEXPEN 50 39 89 155
FLUTICASONE PROPIONATE 50 26 89 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.